| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.54 | 0.008 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.008 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.008 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.008 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.11 | 0.009 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.098 | 0.009 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.009 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |